Manuel Weber - Concepedia

Author

Manuel Weber

University of Duisburg-Essen ORCID

Also Known As

M Weber, M. Weber, Manuel M Weber, Manuel M. Weber, Manuel Weber, Max Yanick Weber, Weber, Manuel

239

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

University of Duisburg-Essen Essen University Hospital Friedrich-Alexander-Universität Erlangen-Nürnberg Deutschen Konsortium für Translationale Krebsforschung Klinikum rechts der Isar

About

Manuel Weber is an author at University of Duisburg-Essen specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	966
2	Health Sciences	6	6	168
3	Cell Biology	4	4	111
4	Cellular Physiology	2	2	29
5	Engineering	1	1	17

Manuel Weber

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer Wolfgang P. Fendler, Manuel Weber, Amir Iravani, Clinical Cancer Research	2019	256
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study Andrei Gafita, Jérémie Calais, Tristan Grogan, The Lancet Oncology	2021	228
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds Manuel Weber, Marnix G. E. H. Lam, Claudio Chiesa, European Journal of Nuclear Medicine and Molecular Imaging Primary Liver TumoursEanm Procedure GuidelineHepatologyRadiation TherapyHepatocellular Carcinoma	2022	207
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis Robert Seifert, Katharina Kessel, Katrin Schlack, European Journal of Nuclear Medicine and Molecular Imaging	2020	140
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study Andrei Gafita, Isabel Rauscher, Manuel Weber, Journal of Nuclear Medicine	2022	128
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities Wolfgang P. Fendler, Kim M. Pabst, Lukas Kessler, Clinical Cancer Research	2022	127
Initial clinical experience with <sup>90</sup>Y-FAPI-46 radioligand therapy for advanced stage solid tumors: a case series of nine patients Justin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, Journal of Nuclear Medicine	2021	111
Pitfalls and Common Findings in<sup>68</sup>Ga-FAPI PET: A Pictorial Analysis Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Journal of Nuclear Medicine	2021	102
Small oral squamous cell carcinomas with nodal lymphogenic metastasis show increased infiltration of M2 polarized macrophages – An immunohistochemical analysis Manuel Weber, Maike Büttner‐Herold, Peter Hyckel, Journal of Cranio-Maxillofacial Surgery Tumor BiologyMedicineOral BiologyCancer Cell BiologyPathology	2014	95
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria Andrei Gafita, Isabel Rauscher, Wolfgang P. Fendler, European Journal of Nuclear Medicine and Molecular Imaging UrologyGenitourinary CancerMedicineCancer ManagementPsma Pet/ct	2022	91

Page 1